Literature DB >> 30228019

Exercise testing in hypertrophic cardiomyopathy: A pathophysiological goldmine with protean clinical implications.

Iacopo Olivotto1, Niccolò Maurizi2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30228019     DOI： 10.1016/j.ijcard.2018.09.044

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  1 in total

1.  Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy.

Authors:  Maria Tafelmeier; Andrea Baessler; Stefan Wagner; Bernhard Unsoeld; Andrej Preveden; Fausto Barlocco; Alessia Tomberli; Dejana Popovic; Paul Brennan; Guy A MacGowan; Arsen Ristic; Lazar Velicki; Iacopo Olivotto; Djordje G Jakovljevic; Lars S Maier
Journal:  Clin Cardiol       Date:  2020-03-03       Impact factor: 2.882
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.